Article
Prospective pan-cancer phosphoproteomics at clinical scale extends therapeutic options in precision oncology
2026-07-09
Abstract excerpt
<h4>SUMMARY</h4> Genomics-guided precision oncology has improved survival in cancer entities with actionable mutations but cannot capture oncogenic signaling that manifests at the protein level. Here, we report a prospective, real-world pan-cancer study profiling proteomes and phosphoproteomes of 1,998 tumor samples from adults and children with rare or advanced cancers enrolled in the German precision oncology p...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 63eb8414-b7d3-5ed5-b900-3d0df0628052
- DOI
- 10.64898/2026.07.08.737171
